SCHEMBL21131860

SCHEMBL21131860

c1ccc(-c2ccc3c(c2)oc2cccc(-c4c5ccccc5c(-c5ccc(-c6ccc7ccccc7c6)cc5)c5ccccc45)c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.38
▸ ESR1 P03372 6/20 0.37
▸ ESR2 Q92731 6/20 0.37
▸ HSD17B1 P14061 3/20 0.37
▸ HSD17B2 P37059 3/20 0.37
▸ PGR P06401 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2B6 P20813 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ GPR84 Q9NQS5 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ MMP12 P39900 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ ANO1 Q5XXA6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109983 0.99 HCRTR1 (0.38) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL24715242 0.97 HCRTR1 (0.38) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL27010153 0.96 HCRTR1 (0.37) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL23428153 0.96 GPR84 (0.37) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL23427654 0.96 GPR84 (0.37) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL29306832 0.96 HCRTR1 (0.38) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL22855158 0.95 HCRTR1 (0.39) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL24173706 0.94 PLA2G2A (0.38) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL20650026 0.92 ESR1 (0.39) HCRTR1ESR1ESR2HSD17B1HSD17B2
SCHEMBL23427211 0.92 CYP1A1 (0.38) HCRTR1HSD17B1HSD17B2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 — — US disclosed
US-20230024114-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2023-01-26 — — US disclosed
US-20220376178-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2022-11-24 — — US disclosed
US-11239425-B2 Organic light emitting device LG CHEM, LTD. (KR) 2022-02-01 — — US disclosed
US-11211563-B2 Organic light emitting device LG CHEM, LTD. (KR) 2021-12-28 — — US disclosed
US-20210399234-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2021-12-23 — — US disclosed
EP-3579292-B1 ORGANIC LIGHT EMITTING DEVICE LG CHEMICAL LTD (KR) 2020-08-05 — — EP disclosed
EP-3498804-B1 ORGANIC LIGHT EMITTING DEVICE LG CHEMICAL LTD (KR) 2020-06-03 — — EP disclosed
EP-3579292-A1 ORGANIC LIGHT EMITTING DEVICE LG Chem, Ltd. (KR) 2019-12-11 — — EP disclosed
US-20190296243-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2019-09-26 — — US disclosed
US-20190198766-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2019-06-27 — — US disclosed
EP-3498804-A1 ORGANIC LIGHT EMITTING DEVICE LG Chem, Ltd. (KR) 2019-06-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 HCRTR1 3958/4885ESR1 3/4885ESR2 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback